After $10B in market value lost, China's WuXi Biologics removed from US unverified list
WuXi Biologics has cause to celebrate as it finds itself removed from the US Department of Commerce’s unverified list.
The China-based contract research and manufacturing giant was initially placed on the list in February of this year after delays in verifications for certain products that were being exported to the US. At the time, the company had been importing items that were subject to US export control, but with the commerce department’s verification process not being able to take place due to Covid-19, it was enough for the company to find its way onto the unverified list. However, WuXi Biologics stressed that it was not blacklisted.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters